My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 102

    1.

    Quantifying the impact of a short-interval interruption of insulin-pump infusion sets on glycemic excursions.

    Zisser H.

    Diabetes Care. 2008 Feb;31(2):238-9. Epub 2007 Dec 4.PMID: 18056889 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Comparison of human regular and lispro insulins after interruption of continuous subcutaneous insulin infusion and in the treatment of acutely decompensated IDDM.

    Attia N, Jones TW, Holcombe J, Tamborlane WV.

    Diabetes Care. 1998 May;21(5):817-21.PMID: 9589247 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Restoring euglycemia in the basal state using continuous glucose monitoring in subjects with type 1 diabetes mellitus.

    Zisser HC, Bevier WC, Jovanovic L.

    Diabetes Technol Ther. 2007 Dec;9(6):509-15.PMID: 18034605 [PubMed - indexed for MEDLINE]Related articles

    4.

    Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. The Study Group for the Development of Pump Therapy in Diabetes.

    Hanaire-Broutin H, Melki V, Bessières-Lacombe S, Tauber JP.

    Diabetes Care. 2000 Sep;23(9):1232-5.PMID: 10977011 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Continuous subcutaneous insulin infusion attenuated glycemic instability in preschool children with type 1 diabetes mellitus.

    Alemzadeh R, Palma-Sisto P, Holzum M, Parton E, Kicher J.

    Diabetes Technol Ther. 2007 Aug;9(4):339-47.PMID: 17705689 [PubMed - indexed for MEDLINE]Related articles

    6.

    Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.

    Raz I, Weiss R, Yegorchikov Y, Bitton G, Nagar R, Pesach B.

    Clin Ther. 2009 May;31(5):980-7.PMID: 19539098 [PubMed - indexed for MEDLINE]Related articles

    7.

    Continuous glucose monitoring in children with type 1 diabetes: before and after insulin pump therapy.

    Heptulla RA, Allen HF, Gross TM, Reiter EO.

    Pediatr Diabetes. 2004 Mar;5(1):10-5.PMID: 15043684 [PubMed - indexed for MEDLINE]Related articles

    8.

    Cessation of insulin infusion at night-time during CSII-therapy: comparison of regular human insulin and insulin lispro.

    Reichel A, Rietzsch H, Köhler HJ, Pfützner A, Gudat U, Schulze J.

    Exp Clin Endocrinol Diabetes. 1998;106(3):168-72.PMID: 9710355 [PubMed - indexed for MEDLINE]Related articles

    9.

    [How should we use the short-acting insulin analog Lys-Pro in external continuous subcutaneous pumps?]

    Guerci B, Jeandidier N, Lassmann-Vague V, Renard E, Hanaire-Broutin H.

    Diabetes Metab. 2000 Dec;26(6):513-9. Review. French. Erratum in: Diabetes Metab 2001 Feb;27(1):86. PMID: 11173725 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine.

    Doyle EA, Weinzimer SA, Steffen AT, Ahern JA, Vincent M, Tamborlane WV.

    Diabetes Care. 2004 Jul;27(7):1554-8.PMID: 15220227 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    The dual-wave bolus feature in continuous subcutaneous insulin infusion pumps controls prolonged post-prandial hyperglycaemia better than standard bolus in Type 1 diabetes.

    Lee SW, Cao M, Sajid S, Hayes M, Choi L, Rother C, de León R.

    Diabetes Nutr Metab. 2004 Aug;17(4):211-6.PMID: 15575341 [PubMed - indexed for MEDLINE]Related articles

    12.

    Optimization of basal insulin delivery in Type 1 diabetes: a retrospective study on the use of continuous subcutaneous insulin infusion and insulin glargine.

    Fahlén M, Eliasson B, Odén A.

    Diabet Med. 2005 Apr;22(4):382-6.PMID: 15787660 [PubMed - indexed for MEDLINE]Related articles

    13.

    Impact of pramlintide on glucose fluctuations and postprandial glucose, glucagon, and triglyceride excursions among patients with type 1 diabetes intensively treated with insulin pumps.

    Levetan C, Want LL, Weyer C, Strobel SA, Crean J, Wang Y, Maggs DG, Kolterman OG, Chandran M, Mudaliar SR, Henry RR.

    Diabetes Care. 2003 Jan;26(1):1-8.PMID: 12502651 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII.

    Hirsch IB, Bode BW, Garg S, Lane WS, Sussman A, Hu P, Santiago OM, Kolaczynski JW; Insulin Aspart CSII/MDI Comparison Study Group.

    Diabetes Care. 2005 Mar;28(3):533-8.PMID: 15735183 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Comparison of metabolic deterioration between insulin analog and regular insulin after a 5-hour interruption of a continuous subcutaneous insulin infusion in type 1 diabetic patients.

    Guerci B, Meyer L, Sallé A, Charrié A, Dousset B, Ziegler O, Drouin P.

    J Clin Endocrinol Metab. 1999 Aug;84(8):2673-8.PMID: 10443658 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control.

    DeVries JH, Snoek FJ, Kostense PJ, Masurel N, Heine RJ; Dutch Insulin Pump Study Group.

    Diabetes Care. 2002 Nov;25(11):2074-80.PMID: 12401759 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    A comparison of insulin lispro and buffered regular human insulin administered via continuous subcutaneous insulin infusion pump.

    Raskin P, Holcombe JH, Tamborlane WV, Malone JI, Strowig S, Ahern JA, Lavent F.

    J Diabetes Complications. 2001 Nov-Dec;15(6):295-300.PMID: 11711322 [PubMed - indexed for MEDLINE]Related articles

    18.

    Post-prandial glucose excursions following four methods of bolus insulin administration in subjects with type 1 diabetes.

    Chase HP, Saib SZ, MacKenzie T, Hansen MM, Garg SK.

    Diabet Med. 2002 Apr;19(4):317-21.PMID: 11943004 [PubMed - indexed for MEDLINE]Related articles

    19.

    Insulin and glucose profiles during continuous subcutaneous insulin infusion compared with injection of a long-acting insulin in Type 2 diabetes.

    Parkner T, Laursen T, Vestergaard ET, Hartvig H, Smedegaard JS, Lauritzen T, Christiansen JS.

    Diabet Med. 2008 May;25(5):585-91.PMID: 18445172 [PubMed - indexed for MEDLINE]Related articles

    20.

    Calculating the insulin to carbohydrate ratio using the hyperinsulinaemic-euglycaemic clamp-a novel use for a proven technique.

    Bevier WC, Zisser H, Palerm CC, Finan DA, Seborg DE, Doyle FJ, Wollitzer AO, Jovanovic L.

    Diabetes Metab Res Rev. 2007 Sep;23(6):472-8.PMID: 17315240 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity